HCMVA (pp65)
Online Inquiry
| CAT# | PPO-H027 |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Purity | >90% (HPLC-MS) |
| Size | 1 vial containing 15 nmol ( 25μg) per peptide |
SwissProt ID | P06725 |
Format | Freeze dried in amber type glass vial |
Topics | Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation |
NumberOfPeptides | 138 |
Organism | Human cytomegalovirus (HHV-5) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Protein Length | 561 |
Protein Name | 65 kDa phosphoprotein (pp65) |
References | 1."The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope". de Souza et al., J. Immunol. 2012 |
Write a review
Ask a question
My Review for HCMVA (pp65)
Required fields are marked with *
×
Ask a Question for HCMVA (pp65)
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
